Kelly Emrick, MBA, Ph.D. https://www.kellyemrick.com

The following explores a recent Centers for Medicare & Medicaid Services data set on U.S. healthcare spending, a significant resource for understanding healthcare costs and gross domestic product (GDP). This data, which includes GDP, implicit price deflator for GDP, and overall national health expenditures (NHE), is the foundation of this investigation. It provides a comprehensive view of these trends from 1960 to 2019, with GDP and national health expenses data points. In the following, I analyze and examine several aspects of NHE, comparing them with GDP growth and the share of healthcare spending relative to GDP over time. A significant disparity in their growth rates emerges after examining the development of GDP and NHE from 1960 to 2019. While both have seen substantial increases, NHE has consistently outpaced GDP growth. This disparity underscores the profound and escalating prominence of healthcare in national spending. Let’s take a closer look at these trends:

GDP Growth:

• In 1960, the GDP was $542 billion.
• By 2019, it had risen to $21,373 billion.
• This reflects an increase of over 38 times the 1960 figure over the 59 years.

National Health Expenditures Growth:

• In 1960, national health expenditures were $27.1 billion.
• By 2019, they had increased to $3,795.4 billion.

This reflects an increase of over 140 times the 1960 figure, significantly outpacing the GDP growth. This comparison shows that national health expenditures have grown much faster than the overall economy, signaling that healthcare has become an increasingly prominent part of national spending. The proportion of GDP devoted to healthcare spending provides an essential measure of the economic burden of healthcare. By comparing national health expenditures to GDP over time, we can identify how healthcare’s share of economic output has changed:

• In 1960, national health expenditures represented 5.0% of GDP.
• In 2019, national health expenditures had grown to represent approximately 17.8% of GDP.

This steady increase indicates that healthcare costs are absorbing a much more significant portion of the nation’s economic resources. Factors contributing to this trend likely include advancements in medical technology, an aging population, higher healthcare costs, and expanded healthcare access. The dataset also allows us to consider the average annual GDP growth rates and national health expenditures over different periods. This can provide more granular insights into how rapidly these two measures increase.

GDP Growth: The average annual growth rate of the GDP, especially in the more recent decades, has been moderate, reflecting the slower growth of mature economies.

• For instance, from 2000 to 2019, the GDP grew from $10.3 trillion to $21.4 trillion, an annual growth rate of approximately 3.2%.

NHE Growth: National health expenditures have exhibited faster growth during the same periods.

• From 2000 to 2019, NHE increased from $1.37 trillion to $3.8 trillion, an annual growth rate of approximately 5.5%.

The data reveals some notable trends over different periods:

1960-1980:

• Healthcare spending grew sharply, with the percentage of GDP allocated to health increasing from 5% to around 9%.
• This period saw the creation of Medicare and Medicaid in 1965, which expanded access to healthcare and contributed to higher spending.

1980-2000:

• Healthcare expenditures grew significantly, from $253.2 billion in 1980 to $1.37 trillion in 2000.
• Technological advances, increased use of diagnostic testing, and higher prices for services likely drove much of this increase.

2000-2019:

• During this period, healthcare costs increased from $1.37 trillion to $3.8 trillion.
• The introduction of the Affordable Care Act in 2010 also expanded access to healthcare, leading to increased spending.
• Advances in pharmaceutical drugs, higher hospitalization costs, and the aging population (as baby boomers aged) all contributed to this rise.

If healthcare spending grows faster than GDP, it could significantly strain both public and private sectors. Key concerns include:

• Government Budgets: With a large proportion of healthcare funded through Medicare and Medicaid, rising costs can lead to significant budgetary pressures on federal and state governments.
• Household Spending: Increasing healthcare costs often result in higher premiums, out-of-pocket expenses, and household burdens.
• Healthcare Access: Rising costs can limit access to care for individuals without adequate insurance or financial resources, exacerbating inequalities in health outcomes.

The increase in NHE in the United States is driven by factors ranging from demographic shifts to advancements in medical technology and systemic issues within the healthcare system. Understanding these drivers requires a multifaceted analysis, as healthcare expenditures are influenced by demand-side factors (such as population characteristics and patient behaviors) and supply-side factors (such as medical technologies and services).

One of the most significant drivers of increasing healthcare costs is the aging population, particularly the growth of the elderly demographic:

• Increased Life Expectancy: Over the past several decades, improvements in healthcare and living conditions have led to longer life expectancies. With individuals living longer, there is an increased demand for healthcare services, particularly for chronic conditions that require long-term management.
• Baby Boomer Generation: The aging of the baby boomer generation (born between 1946 and 1964) has significantly strained the healthcare system. As this large cohort enters retirement age, they tend to consume more healthcare resources, increasing overall expenditures. Older adults typically require more frequent and intensive healthcare, including hospitalizations, long-term care, and pharmaceutical treatments.
• Chronic Disease Prevalence: Aging is associated with a higher prevalence of chronic diseases such as diabetes, heart disease, and arthritis, which necessitate ongoing treatment and monitoring. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for a significant portion of total healthcare expenditures in the U.S. Managing these conditions is costly regarding direct medical care and indirect costs (such as disability and lost productivity).

While technological advancements have greatly improved healthcare outcomes, they have also contributed to rising costs. New technologies and treatments often come with high price tags, and their widespread adoption can significantly drive up expenditures.

• Innovative Treatments and Diagnostics: The development of cutting-edge treatments, such as immunotherapies, targeted cancer therapies, and biologic drugs, has transformed healthcare but at substantial costs. Similarly, advanced diagnostic tools such as MRI machines, CT scans, and genetic testing contribute to rising spending by enabling earlier and more precise diagnoses, often leading to more interventions.
• High-Cost Pharmaceuticals: Prescription drug spending has been one of the fastest-growing components of healthcare costs. New, expensive specialty drugs, including those for rare diseases and cancer, have played a significant role. While these medications can be life-saving, their cost can run into thousands of dollars per treatment or even per dose, which places a financial burden on both the healthcare system and patients.
• Increased Utilization of Technology: The proliferation of medical technology has also contributed to increased utilization rates. For instance, procedures that were once rare and costly, like hip replacements or cardiac surgeries, are now more common due to technological improvements, increasing healthcare spending.

A significant driver of NHE growth is the rising cost of healthcare services. Prices for hospital services, physician fees, and other healthcare-related services have increased at rates above general inflation. Several factors contribute to these rising prices:

• Provider Consolidation: Over the past few decades, there has been a trend toward consolidation among hospitals and healthcare providers. Larger health systems often have greater pricing power when negotiating with insurance companies, leading to higher service prices. Research suggests provider consolidation can lead to monopolistic pricing behaviors, driving costs without improving quality.
• Administrative Costs: The U.S. healthcare system is known for its complex administrative processes associated with higher costs. These include billing, insurance claims processing, and regulatory compliance, representing a substantial portion of healthcare expenditures. The fragmented nature of the healthcare system—comprising private insurers, government programs (Medicare, Medicaid), and other payers—creates inefficiencies and adds administrative layers.
• Labor Costs: As healthcare is a labor-intensive industry, the rising salaries of healthcare professionals, particularly specialists, have also contributed to increasing costs. The demand for healthcare workers has risen sharply due to an aging population and expanded access to care through programs like the Affordable Care Act (ACA), leading to higher compensation for healthcare workers and, in turn, higher costs for healthcare services.

The structure of the U.S. healthcare system is a critical factor in driving up costs. The U.S. has a predominantly privatized healthcare system, which leads to higher administrative costs and less price regulation than other developed countries.

• Fee-for-Service Model: The traditional fee-for-service model, which compensates healthcare providers based on the quantity of care delivered rather than the quality of outcomes, incentivizes overutilization. Providers are often paid for each test, procedure, or visit, which can lead to unnecessary treatments and tests, driving up costs without necessarily improving patient outcomes.
• Lack of Price Transparency: One of the ongoing challenges in the U.S. healthcare system is the lack of price transparency. Patients often do not know the cost of services before receiving care, and prices for the same service can vary dramatically between providers. This opaque pricing system prevents consumers from making cost-conscious decisions and reduces competition, leading to higher prices overall.
• Defensive Medicine: Physicians in the U.S. often engage in “defensive medicine,” ordering additional tests or procedures to avoid potential lawsuits. This contributes to unnecessary healthcare utilization and higher spending without improving patient outcomes.

Expanded access to health insurance has contributed to increasing NHE, particularly since the passage of the Affordable Care Act (ACA) in 2010. The ACA expanded Medicaid eligibility in many states and provided subsidies to help individuals purchase private insurance, resulting in millions of previously uninsured individuals gaining coverage.

• Increased Utilization: With more people insured, there is greater access to healthcare services. Insurance coverage reduces individuals’ out-of-pocket costs, leading to higher utilization of healthcare services. While this expansion has improved access to necessary care, it also increases healthcare expenditures.
• Government Healthcare Programs: Government programs like Medicare (for older people) and Medicaid (for low-income individuals) have significantly expanded. As the populations eligible for these programs grow, so do the costs associated with providing care. For instance, the aging population places increasing demand on Medicare, which is expected to continue as more baby boomers retire.

Lifestyle-related factors such as obesity, smoking, and lack of physical activity have contributed to the rise in chronic diseases, which are significant drivers of healthcare costs.

• Obesity Epidemic: The prevalence of obesity has risen sharply over the past few decades, and it is a significant risk factor for many costly chronic conditions, including heart disease, diabetes, and certain cancers. Treating these conditions requires long-term care and management, which increases NHE.
• Preventable Diseases: Many of the leading causes of death and disability in the U.S., such as cardiovascular diseases, are preventable with lifestyle changes. However, treating these diseases is costly and constitutes a substantial portion of healthcare spending.

Modeling healthcare costs beyond 2030 involves using statistical and econometric techniques to project future trends. Various factors can influence healthcare costs, including demographic shifts, inflation, technological advancements, policy changes, and healthcare demand. An appropriate model based on past trends and future expectations is essential to provide a reliable forecast. I applied a linear regression model to project NHE from 2020 to 2030. For projections beyond 2030, we could continue using this model, but it is essential to acknowledge that linear models may oversimplify reality by assuming constant growth rates. Real-world healthcare costs are often subject to non-linear trends, such as unexpected medical innovations or policy interventions. Given the historical data from 1960 to 2019 and the trends observed, we can extend the linear regression model further, though caution must be taken with long-term projections. The attached graph forecasts 2040 using the existing linear model for simplicity.

Centers for Medicare & Medicaid Services. (2020). National health expenditures by year and GDP, selected years 1960-2019. U.S. Department of Health and Human Services. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData